Combination of Atropine and Ortho-k wins an edge over monotherapy for myopia in young kids
The combination of Atropine with Ortho-k was found to be beneficial in controlling myopia in young kids aged 8-12 years as per a recent study that was published in the British Journal of Ophthalmology.
Myopia is caused due to various factors like genetics, environment, etc. Multiple drugs aid in the management like atropine. Researchers have conducted an age-stratified randomized controlled trial to investigate the 2-year efficacy of the combination of atropine and orthokeratology vs monotherapy and explore the factors influencing their efficacy.
164 children aged 8–12 years with spherical equivalent refraction of −1.00 to −6.00 D were stratified into two age subgroups and randomly assigned to receive placebo drops+spectacles (control), 0.01% atropine+spectacles (atropine), ortho-k+placebo (ortho-k) or combined treatment. Axial length was measured at baseline and visits at 6, 12, 18, and 24 months. The primary analysis was done following the criteria of intention to treat, which included all randomized subjects.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.